130 related articles for article (PubMed ID: 30701618)
21. Histopathological studies of reactions in mice injected with aluminum-adsorbed tetanus toxoid.
Goto N; Akama K
Microbiol Immunol; 1982; 26(12):1121-32. PubMed ID: 7169970
[TBL] [Abstract][Full Text] [Related]
22. Co-administration of a CpG adjuvant (VaxImmune, CPG 7909) with CETP vaccines increased immunogenicity in rabbits and mice.
Thomas LJ; Hammond RA; Forsberg EM; Geoghegan-Barek KM; Karalius BH; Marsh HC; Rittershaus CW
Hum Vaccin; 2009 Feb; 5(2):79-84. PubMed ID: 18670196
[TBL] [Abstract][Full Text] [Related]
23. Effects of adjuvant, dose and carrier pre-sensitisation on the immunisation efficacy of a GnRH analogue.
Ferro VA; Stimson WH
Drug Des Discov; 1996 Dec; 14(3):179-95. PubMed ID: 9017362
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of alum-based adjuvant on the immunogenicity of salmonella enterica serovar typhi conjugates vaccines.
Tritama E; Riani C; Rudiansyah I; Hidayat A; Kharisnaeni SA; Retnoningrum DS
Hum Vaccin Immunother; 2018 Jun; 14(6):1524-1529. PubMed ID: 29359991
[TBL] [Abstract][Full Text] [Related]
25. Roles of Aluminum Hydroxide and Monophosphoryl Lipid A Adjuvants in Overcoming CD4+ T Cell Deficiency To Induce Isotype-Switched IgG Antibody Responses and Protection by T-Dependent Influenza Vaccine.
Ko EJ; Lee YT; Kim KH; Lee Y; Jung YJ; Kim MC; Lee YN; Kang T; Kang SM
J Immunol; 2017 Jan; 198(1):279-291. PubMed ID: 27881702
[TBL] [Abstract][Full Text] [Related]
26. Role of alum in improving the immunogenicity of biodegradable polymer particle entrapped antigens.
Kanchan V; Katare YK; Panda AK
Eur J Pharm Sci; 2009 Aug; 38(1):18-28. PubMed ID: 19467323
[TBL] [Abstract][Full Text] [Related]
27. Design and preclinical characterization of a novel vaccine adjuvant formulation consisting of a synthetic TLR4 agonist in a thermoreversible squalene emulsion.
Haensler J; Probeck P; Su J; Piras F; Dalençon F; Cotte JF; Chambon V; Iqbal SM; Hawkins L; Burdin N
Int J Pharm; 2015; 486(1-2):99-111. PubMed ID: 25794609
[TBL] [Abstract][Full Text] [Related]
28. The Preparation and Physicochemical Characterization of Aluminum Hydroxide/TLR7a, a Novel Vaccine Adjuvant Comprising a Small Molecule Adsorbed to Aluminum Hydroxide.
Malyala P; Laera D; Cianetti S; Bufali S; Aggravi M; Ianni E; Judge C; Otten G; Singh M; O'Hagan DT
J Pharm Sci; 2018 Jun; 107(6):1577-1585. PubMed ID: 29421216
[TBL] [Abstract][Full Text] [Related]
29. Novel adjuvant Alum-TLR7 significantly potentiates immune response to glycoconjugate vaccines.
Buonsanti C; Balocchi C; Harfouche C; Corrente F; Galli Stampino L; Mancini F; Tontini M; Malyala P; Bufali S; Baudner B; De Gregorio E; Valiante NM; O'Hagan DT; Rappuoli R; D'Oro U
Sci Rep; 2016 Jul; 6():29063. PubMed ID: 27439378
[TBL] [Abstract][Full Text] [Related]
30. Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.
Bungener L; Geeraedts F; Ter Veer W; Medema J; Wilschut J; Huckriede A
Vaccine; 2008 May; 26(19):2350-9. PubMed ID: 18400340
[TBL] [Abstract][Full Text] [Related]
31. A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide.
Men Y; Thomasin C; Merkle HP; Gander B; Corradin G
Vaccine; 1995 May; 13(7):683-9. PubMed ID: 7668038
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of peptide based epsilon toxin vaccine by covalent anchoring to tetanus toxoid.
Kaushik H; Dixit A; Garg LC
Anaerobe; 2018 Oct; 53():50-55. PubMed ID: 29920342
[TBL] [Abstract][Full Text] [Related]
33. Microcrystalline Tyrosine and Aluminum as Adjuvants in Allergen-Specific Immunotherapy Protect from IgE-Mediated Reactivity in Mouse Models and Act Independently of Inflammasome and TLR Signaling.
Leuthard DS; Duda A; Freiberger SN; Weiss S; Dommann I; Fenini G; Contassot E; Kramer MF; Skinner MA; Kündig TM; Heath MD; Johansen P
J Immunol; 2018 May; 200(9):3151-3159. PubMed ID: 29592962
[TBL] [Abstract][Full Text] [Related]
34. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the adjuvant effect of agonists of toll-like receptor 4 and 7/8 in a vaccine against leishmaniasis in BALB/c mice.
Rostamian M; Niknam HM
Mol Immunol; 2017 Nov; 91():202-208. PubMed ID: 28963929
[TBL] [Abstract][Full Text] [Related]
36. AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity.
Didierlaurent AM; Morel S; Lockman L; Giannini SL; Bisteau M; Carlsen H; Kielland A; Vosters O; Vanderheyde N; Schiavetti F; Larocque D; Van Mechelen M; Garçon N
J Immunol; 2009 Nov; 183(10):6186-97. PubMed ID: 19864596
[TBL] [Abstract][Full Text] [Related]
37. Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant.
Dillon SB; Demuth SG; Schneider MA; Weston CB; Jones CS; Young JF; Scott M; Bhatnaghar PK; LoCastro S; Hanna N
Vaccine; 1992; 10(5):309-18. PubMed ID: 1349448
[TBL] [Abstract][Full Text] [Related]
38. Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus.
Bagnoli F; Fontana MR; Soldaini E; Mishra RP; Fiaschi L; Cartocci E; Nardi-Dei V; Ruggiero P; Nosari S; De Falco MG; Lofano G; Marchi S; Galletti B; Mariotti P; Bacconi M; Torre A; Maccari S; Scarselli M; Rinaudo CD; Inoshima N; Savino S; Mori E; Rossi-Paccani S; Baudner B; Pallaoro M; Swennen E; Petracca R; Brettoni C; Liberatori S; Norais N; Monaci E; Bubeck Wardenburg J; Schneewind O; O'Hagan DT; Valiante NM; Bensi G; Bertholet S; De Gregorio E; Rappuoli R; Grandi G
Proc Natl Acad Sci U S A; 2015 Mar; 112(12):3680-5. PubMed ID: 25775551
[TBL] [Abstract][Full Text] [Related]
39. MF59 oil-in-water emulsion in combination with a synthetic TLR4 agonist (E6020) is a potent adjuvant for a combination Meningococcus vaccine.
Singh M; Kazzaz J; Ugozzoli M; Baudner B; Pizza M; Giuliani M; Hawkins LD; Otten G; O'Hagan DT
Hum Vaccin Immunother; 2012 Apr; 8(4):486-90. PubMed ID: 22832252
[TBL] [Abstract][Full Text] [Related]
40. Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid.
Gupta RK; Siber GR
Biologicals; 1994 Mar; 22(1):53-63. PubMed ID: 8068314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
